2.22
price up icon0.91%   0.02
after-market 시간 외 거래: 2.22
loading
전일 마감가:
$2.20
열려 있는:
$2.24
하루 거래량:
27,760
Relative Volume:
0.62
시가총액:
$3.23M
수익:
-
순이익/손실:
$-10.38M
주가수익비율:
-0.4436
EPS:
-5.0046
순현금흐름:
$-12.45M
1주 성능:
-9.39%
1개월 성능:
+6.99%
6개월 성능:
-53.56%
1년 성능:
-88.17%
1일 변동 폭
Value
$2.20
$2.33
1주일 범위
Value
$2.1501
$2.55
52주 변동 폭
Value
$1.70
$26.47

Avenue Therapeutics Inc Stock (ATXI) Company Profile

Name
명칭
Avenue Therapeutics Inc
Name
전화
781-652-4500
Name
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
직원
3
Name
트위터
@avenuethera
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
ATXI's Discussions on Twitter

Avenue Therapeutics Inc 주식(ATXI)의 최신 뉴스

pulisher
Oct 30, 2024

Drug Resistant Epilepsy Market Size, Industry Analysis, - openPR

Oct 30, 2024
pulisher
Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024
pulisher
Oct 20, 2024

NYC officials envision turning Fifth Avenue into a grand boulevard | Company Business News - Mint

Oct 20, 2024
pulisher
Oct 17, 2024

Avenue Therapeutics stock hits 52-week low at $1.89 By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 15, 2024

Avenue Therapeutics stock hits 52-week low at $1.89 - Investing.com

Oct 15, 2024
pulisher
Oct 14, 2024

Park Avenue Securities LLC Reduces Position in Morningstar, Inc. (NASDAQ:MORN) - Defense World

Oct 14, 2024
pulisher
Oct 12, 2024

DMart Q2 Results: Avenue Supermarts net profit rises 5.77% to ₹659.58 crore, revenue up 14.41% YoY | Company Business News - Mint

Oct 12, 2024
pulisher
Oct 10, 2024

IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Park Avenue Securities LLC - Defense World

Oct 10, 2024
pulisher
Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024
pulisher
Oct 09, 2024

Avenue Therapeutics To Participate In Maxim Group’s 2024 Healthcare Virtual Summit - Barchart

Oct 09, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. - GlobeNewswire

Oct 07, 2024
pulisher
Oct 04, 2024

Avenue Therapeutics stock hits 52-week low at $2.17 By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Avenue Therapeutics stock hits 52-week low at $2.17 - Investing.com

Oct 04, 2024
pulisher
Oct 02, 2024

Avenue Therapeutics director buys shares worth $1,249 By Investing.com - Investing.com South Africa

Oct 02, 2024
pulisher
Oct 01, 2024

Avenue Therapeutics director buys shares worth $1,249 - Investing.com India

Oct 01, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Increases Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

Avenue Therapeutics grants stock units to top executives By Investing.com - Investing.com Canada

Sep 28, 2024
pulisher
Sep 27, 2024

Avenue Therapeutics grants stock units to top executives - Investing.com India

Sep 27, 2024
pulisher
Sep 27, 2024

Avenue Therapeutics Incentive Plan Awards Key Executives - TipRanks

Sep 27, 2024
pulisher
Sep 26, 2024

FBIOFortress Biotech, Inc. Latest Stock News & Market Updates - StockTitan

Sep 26, 2024
pulisher
Sep 25, 2024

Neurological diseases index falls; Sarepta and Intra-Cellular report gains - BioWorld Online

Sep 25, 2024
pulisher
Sep 24, 2024

Avenue Therapeutics stock hits 52-week low at $2.23 By Investing.com - Investing.com Canada

Sep 24, 2024
pulisher
Sep 24, 2024

Avenue Therapeutics stock hits 52-week low at $2.23 - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Avenue Supermart shares rise 1.49% as Sensex climbs - The Economic Times

Sep 24, 2024
pulisher
Sep 24, 2024

Avenue Supermart rises 1.49% as Sensex climbs - The Economic Times

Sep 24, 2024
pulisher
Sep 23, 2024

Share price of Avenue Supermart falls as Sensex gains 251.05 points - The Economic Times

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Forest Avenue Capital Management LP Has $44.92 Million Position in Walmart Inc. (NYSE:WMT) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Postoperative acute pain Market Size is Set for Rapid Growth as - openPR

Sep 21, 2024
pulisher
Sep 21, 2024

Forest Avenue Capital Management LP Has $24.54 Million Holdings in GE Vernova Inc. (NYSE:GEV) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Australia's Amplia Therapeutics rises as US FDA fast-tracks cancer drug - XM

Sep 19, 2024
pulisher
Sep 19, 2024

Amplia Therapeutics’ Drug Fast-Tracked by FDA - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

First Avenue IPO on Nomu 740% oversubscribed; offer price set at SAR 6 - بوابة أرقام المالية

Sep 19, 2024
pulisher
Sep 19, 2024

Avenue Supermart shares down 0.27% as Nifty gains - The Economic Times

Sep 19, 2024
pulisher
Sep 19, 2024

Avenue Supermart shares fall 0.27 per cent in Thursday's trading session - The Economic Times

Sep 19, 2024
pulisher
Sep 18, 2024

Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - AccessWire

Sep 18, 2024
pulisher
Sep 18, 2024

Avenue Supermart shares up 0.35% as Nifty gains - The Economic Times

Sep 18, 2024
pulisher
Sep 17, 2024

SEC Form S-3 filed by Brainstorm Cell Therapeutics Inc. - Quantisnow

Sep 17, 2024
pulisher
Sep 16, 2024

2 Dead In Series Of Police Shootouts That Shut Down Victory Boulevard - Patch

Sep 16, 2024
pulisher
Sep 16, 2024

Meet Microsoft’s new COO—a former superstar CFO from GE - Fortune

Sep 16, 2024
pulisher
Sep 16, 2024

Share price of Avenue Supermart rises as Nifty strengthens - The Economic Times

Sep 16, 2024
pulisher
Sep 13, 2024

Allarity Therapeutics appoints new CFO - Investing.com India

Sep 13, 2024
pulisher
Sep 13, 2024

Allarity Therapeutics expands ATM agreement, appoints new CFO - Investing.com

Sep 13, 2024
pulisher
Sep 13, 2024

Allarity Therapeutics appoints new CFO By Investing.com - Investing.com Australia

Sep 13, 2024
pulisher
Sep 13, 2024

Allarity Therapeutics Names Alex Epshinsky Finance Chief - MarketWatch

Sep 13, 2024
pulisher
Sep 13, 2024

Allarity appoints Alex Epshinsky as CFO - TipRanks

Sep 13, 2024
pulisher
Sep 13, 2024

Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 13, 2024
pulisher
Sep 03, 2024

Avenue Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Sep 03, 2024
pulisher
Sep 03, 2024

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - The Malaysian Reserve

Sep 03, 2024
pulisher
Aug 27, 2024

New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways - ACS Publications

Aug 27, 2024
pulisher
Aug 26, 2024

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 26, 2024

Avenue Therapeutics Inc (ATXI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Avenue Therapeutics Inc 주식 (ATXI) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
KRANZLER JAY D
Director
Sep 27 '24
Buy
2.40
3
7
123
Davidow Robert L
10% Owner
Dec 11 '23
Sale
0.14
353,000
49,600
22,000
Davidow Robert L
10% Owner
Dec 11 '23
Sale
0.14
264,000
36,960
681,000
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):